These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39282196)

  • 1. The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review.
    Dubey S; Siddiqui AH; Sharma M
    Indian J Microbiol; 2024 Sep; 64(3):846-858. PubMed ID: 39282196
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Lu W; Zhou S; Ma X; Xu N; Liu D; Zhang K; Zheng Y; Wu S
    Microbiol Spectr; 2024 Feb; 12(2):e0254223. PubMed ID: 38149860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel fosfomycin resistance gene fosY is present on a genomic island in CC1 methicillin-resistant
    Chen Y; Ji S; Sun L; Wang H; Zhu F; Chen M; Zhuang H; Wang Z; Jiang S; Yu Y; Chen Y
    Emerg Microbes Infect; 2022 Dec; 11(1):1166-1173. PubMed ID: 35332834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile fosfomycin resistance genes in Enterobacteriaceae-An increasing threat.
    Zurfluh K; Treier A; Schmitt K; Stephan R
    Microbiologyopen; 2020 Dec; 9(12):e1135. PubMed ID: 33128341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of
    Huang Y; Lin Q; Zhou Q; Lv L; Wan M; Gao X; Wang C; Liu JH
    Infect Drug Resist; 2020; 13():1273-1279. PubMed ID: 32431524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of FosL1, a Plasmid-Encoded Fosfomycin Resistance Protein Identified in Escherichia coli.
    Kieffer N; Poirel L; Descombes MC; Nordmann P
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora.
    Ten Doesschate T; Abbott IJ; Willems RJL; Top J; Rogers MRC; Bonten MM; Paganelli FL
    J Antimicrob Chemother; 2019 Dec; 74(12):3630-3632. PubMed ID: 31511878
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of FosA8, a Plasmid-Encoded Fosfomycin Resistance Determinant from Escherichia coli, and Its Origin in Leclercia adecarboxylata.
    Poirel L; Vuillemin X; Kieffer N; Mueller L; Descombes MC; Nordmann P
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial.
    Kaye KS; Rice LB; Dane AL; Stus V; Sagan O; Fedosiuk E; Das AF; Skarinsky D; Eckburg PB; Ellis-Grosse EJ
    Clin Infect Dis; 2019 Nov; 69(12):2045-2056. PubMed ID: 30861061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant Gram-negative infection in solid organ transplant recipients: implications for outcome and treatment.
    Silva JT; Fernández-Ruiz M; Aguado JM
    Curr Opin Infect Dis; 2018 Dec; 31(6):499-505. PubMed ID: 30299353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci.
    Coronado-Álvarez NM; Parra D; Parra-Ruiz J
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Jan; 37(1):4-10. PubMed ID: 29907368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to manage
    Bassetti M; Vena A; Croxatto A; Righi E; Guery B
    Drugs Context; 2018; 7():212527. PubMed ID: 29872449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
    Papst L; Beović B; Pulcini C; Durante-Mangoni E; Rodríguez-Baño J; Kaye KS; Daikos GL; Raka L; Paul M;
    Clin Microbiol Infect; 2018 Oct; 24(10):1070-1076. PubMed ID: 29410094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin: Pharmacological, Clinical and Future Perspectives.
    Dijkmans AC; Zacarías NVO; Burggraaf J; Mouton JW; Wilms EB; van Nieuwkoop C; Touw DJ; Stevens J; Kamerling IMC
    Antibiotics (Basel); 2017 Oct; 6(4):. PubMed ID: 29088073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Biofilm in Cerebrospinal Fluid Shunt Infections: A Study at Tertiary Neurocare Center from South India.
    Benachinmardi KK; Ravikumar R; Indiradevi B
    J Neurosci Rural Pract; 2017; 8(3):335-341. PubMed ID: 28694609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.
    Gutiérrez-Gutiérrez B; Salamanca E; de Cueto M; Hsueh PR; Viale P; Paño-Pardo JR; Venditti M; Tumbarello M; Daikos G; Cantón R; Doi Y; Tuon FF; Karaiskos I; Pérez-Nadales E; Schwaber MJ; Azap ÖK; Souli M; Roilides E; Pournaras S; Akova M; Pérez F; Bermejo J; Oliver A; Almela M; Lowman W; Almirante B; Bonomo RA; Carmeli Y; Paterson DL; Pascual A; Rodríguez-Baño J;
    Lancet Infect Dis; 2017 Jul; 17(7):726-734. PubMed ID: 28442293
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Lepak AJ; Zhao M; VanScoy B; Taylor DS; Ellis-Grosse E; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).
    de Cueto M; Aliaga L; Alós JI; Canut A; Los-Arcos I; Martínez JA; Mensa J; Pintado V; Rodriguez-Pardo D; Yuste JR; Pigrau C
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):314-320. PubMed ID: 28017477
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.